Non-Marketing of Informant’s Supplement Product Due to Non-Cooperation of OPs Didn’t Raise Any Competition Issue; Plea Rejected | CCI
- News|Blog|Competition Law|
- 2 Min Read
- By Taxmann
- |
- Last Updated on 7 May, 2024
Latest from Taxmann
Case Details: Somnath Banerjee v. Apex Lab - [2024] 162 taxmann.com 132 (CCI)
Judiciary and Counsel Details
-
- Ms Ravneet Kaur, Chairperson, Anil Agrawal, Ms Sweta Kakkad & Deepak Anurag, Member
Facts of the Case
In the instant case, the informant was a pharmacist and holder of Patent No 395566 granted on 27.04.2022 by Patent Office, Govt. of India. As per Patent Certificate, invention i.e. ‘An Oral Rehydration Powder Composition Comprising Papain’ was stated to be a dietary supplement/ modified ORS, which improves digestion, reduces pain and inflammation etc.
The Informant was primarily aggrieved by the non-marketing of its patented dietary supplement (sold under the brand name Protestin) due to the alleged non-cooperation of private hospitals, Federation of Medical and Sales Representatives, online pharmacies, MNCs, distributors, doctors, exporters, Indian Drug Manufacturers’ Association, medicines shops, etc. (OPs).
Further, the Informant stated that the alleged conduct of OPs was in contravention of Section 3(4) and Section 3(1) of the Competition Act, 2002.
CCI Held
The Competition Commission of India noted that commercial considerations of market players drove the decision of purchase or sale of a product and quantity thereof. Further, there was no agreement or arrangement as envisaged under provisions of Section 3(4), and thus, there was no apparent anti-competitive conduct.
The Competition Commission of India held that there was no contravention of provisions of section 3(4), read with section 3(1), and thus, the matter was to be closed under section 26 of the Competition Act, 2002.
Disclaimer: The content/information published on the website is only for general information of the user and shall not be construed as legal advice. While the Taxmann has exercised reasonable efforts to ensure the veracity of information/content published, Taxmann shall be under no liability in any manner whatsoever for incorrect information, if any.
Taxmann Publications has a dedicated in-house Research & Editorial Team. This team consists of a team of Chartered Accountants, Company Secretaries, and Lawyers. This team works under the guidance and supervision of editor-in-chief Mr Rakesh Bhargava.
The Research and Editorial Team is responsible for developing reliable and accurate content for the readers. The team follows the six-sigma approach to achieve the benchmark of zero error in its publications and research platforms. The team ensures that the following publication guidelines are thoroughly followed while developing the content:
- The statutory material is obtained only from the authorized and reliable sources
- All the latest developments in the judicial and legislative fields are covered
- Prepare the analytical write-ups on current, controversial, and important issues to help the readers to understand the concept and its implications
- Every content published by Taxmann is complete, accurate and lucid
- All evidence-based statements are supported with proper reference to Section, Circular No., Notification No. or citations
- The golden rules of grammar, style and consistency are thoroughly followed
- Font and size that’s easy to read and remain consistent across all imprint and digital publications are applied
Sign Up
To subscribe to our weekly newsletter please log in/register on Taxmann.com
Latest Books
Everything on Tax and Corporate Laws of India
To subscribe to our weekly newsletter please log in/register on Taxmann.com
CA | CS | CMA
